{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:54:18Z","timestamp":1773320058373,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cct.2011.01.005","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:37:14Z","timestamp":1296121034000},"page":"333-338","source":"Crossref","is-referenced-by-count":23,"title":["Co-enrollment in multiple HIV prevention trials \u2014 Experiences from the CAPRISA 004 Tenofovir gel trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Quarraisha Abdool","family":"Karim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha B.M.","family":"Kharsany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasavan","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla","family":"Yende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanuja","family":"Gengiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaheen","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Arulappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koleka P.","family":"Mlisana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Londiwe R.","family":"Luthuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S. Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2011.01.005_bb0005","series-title":"AIDS epidemic update: November 2009. \u201cUNAIDS\/0936E\/JC1700E\u201d ISBN 978 92 9173 832 8 (NLM classification: WC 50341)","author":"UNAIDS World Health Organization","year":"2009"},{"key":"10.1016\/j.cct.2011.01.005_bb0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0140-6736(08)60885-5","article-title":"Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward","volume":"372","author":"Padian","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.01.005_bb0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0b013e328337798a","article-title":"Weighing the gold in the gold standard: challenges in HIV prevention research","volume":"24","author":"Padian","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2011.01.005_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2702.2003.00662.x","article-title":"Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions","volume":"12","author":"Evans","year":"2003","journal-title":"Journal of Clinical Nursing"},{"key":"10.1016\/j.cct.2011.01.005_bb0025","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.01.005_bb0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"Van Damme","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.cct.2011.01.005_bb0035","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","article-title":"Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial","volume":"360","author":"Van Damme","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.01.005_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(07)60950-7","article-title":"Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial","volume":"370","author":"Padian","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.01.005_bb0045","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cct.2011.01.005_bb0050","series-title":"Conference on Opportunistic Infections and Retroviruses. 8 February 2009; Montreal","article-title":"Safety and Effectiveness of Vaginal Microbicides BufferGel and PRO 2000 Gel for the Prevention of HIV Infection in Women: Results of the HPTN 035 Trial. [abstract 48lb].","author":"Abdool Karim","year":"2009"},{"key":"10.1016\/j.cct.2011.01.005_bb0055","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00228-007-0368-3","article-title":"Why healthy subjects volunteer for phase I studies and how they perceive their participation?","volume":"63","author":"Almeida","year":"2007","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.cct.2011.01.005_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1745-6215-11-31","article-title":"Reasons for participating in randomised controlled trials: conditional altruism and considerations for self","volume":"11","author":"McCann","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.cct.2011.01.005_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.qai.0000152039.88422.ec","article-title":"Motivations for participating in an HIV vaccine efficacy trial","volume":"39","author":"Colfax","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.cct.2011.01.005_bb0070","first-page":"1","article-title":"Preventing overlapping enrollment in clinical studies","volume":"6","author":"Boyar","year":"2010","journal-title":"Journal of Clinical Research Best Practices"},{"key":"10.1016\/j.cct.2011.01.005_bb0075","doi-asserted-by":"crossref","unstructured":"Abdool Karim Q, Kharsany A, Frohlich J, Werner L, Mashego M, Mlotshwa M, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. International Journal of Epidemiology, online November 3, 2010, doi:10.1093\/ije\/dyq176.","DOI":"10.1093\/ije\/dyq176"},{"key":"10.1016\/j.cct.2011.01.005_bb0080","doi-asserted-by":"crossref","first-page":"e1954","DOI":"10.1371\/journal.pone.0001954","article-title":"Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study","volume":"3","author":"van Loggerenberg","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cct.2011.01.005_bb0085","series-title":"Statement on co-enrollment of participants in CAPRISA 004 and HPTN 035 in South Africa. (Microbicide Trials Network)","author":"Sharon Hillier","year":"2008"},{"key":"10.1016\/j.cct.2011.01.005_bb0090","series-title":"ICH harmonised tripartate guideline statistical principles for clinical trials-E9","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use","author":"International Conference on Harmonisation Guidelines E9","year":"1998"},{"key":"10.1016\/j.cct.2011.01.005_bb0095","first-page":"95","article-title":"Clinical trial remuneration: the patients' perspective","volume":"98","author":"Burgess","year":"2008","journal-title":"South African Medical Journal"},{"key":"10.1016\/j.cct.2011.01.005_bb0100","first-page":"926","article-title":"Payment of trial participants can be ethically sound: moving past a flat rate","volume":"98","author":"Koen","year":"2008","journal-title":"South African Medical Journal"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T07:27:20Z","timestamp":1543994840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714411000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1551714411000073"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2011.01.005","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}